发明名称 Lantibiotics and uses thereof
摘要 The present invention provides isolated lantibiotics that inhibit. Gram negative and Gram positive microbes. The antibiotic includes an amino acid sequence, wherein the amino acid sequence of the compound and the amino acid sequence of SEQ ID NO:21 or SEQ ID NO:22 have at least 80% identity. The lantibiotics have the characteristic of inhibiting growth of a Gram negative microbe in conditions that do not damage the outer membrane of the Gram negative microbe. The present invention also provides methods for making and using the lantibiotics.
申请公布号 US8933193(B2) 申请公布日期 2015.01.13
申请号 US201113100005 申请日期 2011.05.03
申请人 Regents of the University of Minnesota 发明人 O'Sullivan Daniel J.;Lee Ju-Hoon
分类号 C07K14/195;A61K38/00;A61K9/14;C12N1/20;A01N63/02;A01N63/00 主分类号 C07K14/195
代理机构 Mueting, Raasch & Gebhardt, P.A. 代理人 Mueting, Raasch & Gebhardt, P.A.
主权项 1. A composition comprising a lantibiotic and a food product, wherein the lantibiotic is not inactivated by digestion with trypsin at 25° C. for 24 hours, wherein the amino acid sequence of the compound and the amino acid sequence of SEQ ID NO:21 have at least 80% identity, and wherein SEQ ID NO:21 is proline-alanine-Xaa1-leucine-Xaa2-phenylalanine-alanine-valine-Xaa3-valine-leucine-Xaa4-valine-Xaa5-phenylalanine-Xaa6-alanine-Xaa7-Xaa8-valine-Xaa9-valine-valine-Xaa10-arginine-leucine-alanine-Xaa11-Xaa12-glycine-asparagine-Xaa13-lysine, where Xaa1, 2, 3, 4, 5, 6, 8, and 11 are each independently serine, didehydroalanine, or alanine, Xaa7, 12, and 13 are each independently cysteine or alanine, and Xaa9 and 10 are each independently threonine, didehydrobutyrine, or 2-aminobutyric acid.
地址 Minneapolis MN US